Neuros Medical
Aliso Viejo, California, United States · Biotechnology, Health Care, Medical
Neuros is dedicated to helping amputees suffering from chronic phantom and residual limb pain find lasting relief. Our mission is to reduce pain-induced opioid dependency, enhance mental well-being, and restore quality of life. We are developing a novel technology designed to turn this vision into reality.
Key facts
- Headquarters
- Aliso Viejo, California, United States
- Employees
- 48
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- neurosmedical.com
- Company page
Recent activity at Neuros Medical
- : Neuros Medical Appoints Thomas Tovello as Chief Financial Officer
- : Neuros Medical
- : Neuros Medical raises $56M in Series D funding led by EQT Life Sciences to commercialize the Altius® System for chronic post-amputation pain.
- : Neuros Medical, Inc. Appoints Zach Stassen as Chief Financial Officer and Kirk Ellis as Vice President of U.S. Sales
- : Neuros Medical
- : Neuros Medical
- : Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
- : Neuros Medical, Inc.
- : Neuros Medical, Inc.
- : Neuros Medical, Inc.
Neuros Medical funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Venture | $56.0M |
| Jul 2025 | Series D | $56.0M |
| Sep 2023 | Venture | $20.0M |
| Dec 2022 | Venture | $8.2M |
| Jan 2021 | Series B | $38.0M |
Leadership
- Thomas Wilder, Executive Officer, Director
- Casey Tansey, Director
- William Harrington, Director
- Anthony Natale, Director
- Marc-Andre Marcotte, Director
- Joyce Erony, Director
Verified email and direct lines for Neuros Medical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Neuros Medical files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Neuros Medical in the news
- Neuros Medical Secures $56M Series D to Commercialize the Altius® System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain - PR Newswire (Jul 09, 2025)
- Neuros Medical reports first commercial implant of Altius system - MassDevice (Jul 23, 2025)
- Neuros Medical Strengthens Senior Leadership Team in Preparation for Commercialization of the Altius® System - BioSpace (Jun 05, 2024)
- Neuros Medical Appoints Thomas Tovello as Chief Financial Officer - PR Newswire (Jul 23, 2026)
- Neuros Medical Announces First Commercial Implant of the Altius® Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain - PR Newswire (Jul 23, 2025)
- Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System - PR Newswire (Jun 29, 2021)
Companies similar to Neuros Medical
- New Age Medical · Biotechnology, Health Care, Medical
- DeepSight Technology · Biotechnology, Health Care, Medical
- Leapcure · Biotechnology, Health Care, Medical
- Pixee Medical · Biotechnology, Health Care, Medical
- Verséa Ophthalmics · Biotechnology, Health Care, Medical
About Neuros Medical: questions and answers
What does Neuros Medical do?
Neuros is dedicated to helping amputees suffering from chronic phantom and residual limb pain find lasting relief. Our mission is to reduce pain-induced opioid dependency, enhance mental well-being, and restore quality of life. We are developing a novel technology designed to turn this vision into reality.
Where is Neuros Medical headquartered?
Neuros Medical is headquartered in Aliso Viejo, California, United States.
How many employees does Neuros Medical have?
Neuros Medical has about 48 employees.
Has Neuros Medical raised funding?
Yes. Fundz has recorded 5 funding events for Neuros Medical. The most recent, $56.0M, was in Aug 2025.
What is the latest news on Neuros Medical?
On Jul 23, 2026, Neuros Medical Appoints Thomas Tovello as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy